Rocket Doctor Is Now In-Network for Aetna in New York State for Medicare and Commercial Health Insurance

•      Rocket Doctor is now in-network with Aetna, having been fully credentialed for Medicare and Commercial insurance in New York State.
  
  
•      Aetna is one of the nation’s largest health insurers, covering 39 million members across 16 states.
  
  
•      Aetna members in New York now have in-network access to Rocket Doctor’s providers and digital health platform, including urgent care, chronic disease management, preventive and mental health services.
  
  
•      Rocket Doctor is already active in New York through its partnership with EngageWell IPA and the CVS Health Foundation’s Healthy Aging Program.
  
  
•      Credentialing strengthens Rocket Doctor AI’s U.S. market presence and mission to improve healthcare access, affordability and equity.

New York, NY , Sept. 04, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with Aetna in New York State, having been fully credentialed for Medicare and commercial plans.

This milestone expands Rocket Doctor’s ability to provide in-network care to Aetna members throughout the state. By combining urgent care, primary care and mental health, alongside connected medical devices and proprietary software, Rocket Doctor delivers high-quality care virtually that is both affordable and accessible, especially for patients on Medicaid and Medicare, and in rural and underserved communities.

“Being credentialed with Aetna in New York is an exciting step forward in our journey to make healthcare more accessible and equitable,” said Dr. William Cherniak, Chief Executive Officer of Rocket Doctor Inc. “Aetna members across the state can now benefit from Rocket Doctor’s digital-first approach to care, which empowers physicians and reduces barriers for patients. This milestone builds on our active partnerships in New York and reinforces our commitment to transforming healthcare delivery for the better.”

Rocket Doctor’s programs include urgent care, chronic disease management, preventive health and mental health services, enabling patients to see licensed physicians from home. With in-network status, Aetna members in New York can access these services with lower out-of-pocket costs and greater convenience.

Rocket Doctor is also active in New York through its partnership with EngageWell IPA and the CVS Health Foundation, which launched the Healthy Aging Program earlier this year. The pilot initiative provides free, virtual health screenings for adults over 60 in New York City, including assessments for heart health, cognitive function and mental health, along with personalized follow-up support from community health workers. The program, backed by $1 million in CVS Health Foundation funding, is designed to help older adults age with confidence, care and convenience.

Rocket Doctor AI continues to expand its payer and health system partnerships across North America. As part of this growth, the company also announced that its new U.S. over-the-counter (OTC) ticker symbol is AIRDF.

Further, the Company has granted 64,896 restricted share units (“RSUs”) and 16,224 stock options (“Options”) to a consultant of Rocket Doctor Inc., the Company’s wholly-owned subsidiary.  The Options are each exercisable for one common share of the Company at an exercise price of C$0.67 per share for a period of three years from the grant date and vest over a one-year term. The RSUs are valid for a term of three years and vest over a one-year term. The Options and RSUs are subject to the terms of the Company’s equity plans and applicable securities law hold periods.

About Rocket Doctor AI Inc.

Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.

Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 300 MDs to provide care to more than 700,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.

By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare - making it more scalable, equitable, and patient-centered.

To learn more about Rocket Doctor AI Inc’s products and services, contact:

www.rocketdoctor.ai  or email: info@rocketdoctor.ai

FOR ADDITIONAL INFORMATION, CONTACT:

Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai

Dr. Bill Cherniak, CEO, Rocket Doctor Inc.
bill@rocketdoctor.io

For media inquiries, contact: media@rocketdoctor.ai
Call: +1 (778) 819 8321

Cautionary Statements

This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Offering, the use of proceeds of the Offering, the filing of a Prospectus Supplement and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.'s expectations include other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.